Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI108831

Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function Test

Arthur E. Broadus, Jane E. Mahaffey, Frederic C. Bartter, and Robert M. Neer

Hypertension-Endocrine Branch, National Heart and Lung Institute, Bethesda, Maryland 20014

Endocrine Division, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Broadus, A. in: PubMed | Google Scholar

Hypertension-Endocrine Branch, National Heart and Lung Institute, Bethesda, Maryland 20014

Endocrine Division, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Mahaffey, J. in: PubMed | Google Scholar

Hypertension-Endocrine Branch, National Heart and Lung Institute, Bethesda, Maryland 20014

Endocrine Division, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Bartter, F. in: PubMed | Google Scholar

Hypertension-Endocrine Branch, National Heart and Lung Institute, Bethesda, Maryland 20014

Endocrine Division, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Neer, R. in: PubMed | Google Scholar

Published October 1, 1977 - More info

Published in Volume 60, Issue 4 on October 1, 1977
J Clin Invest. 1977;60(4):771–783. https://doi.org/10.1172/JCI108831.
© 1977 The American Society for Clinical Investigation
Published October 1, 1977 - Version history
View PDF
Abstract

Nephrogenous cyclic AMP (NcAMP), total cyclic AMP excretion (UcAMP), and plasma immunoreactive parathyroid hormone (iPTH), determined with a multivalent antiserum, were prospectively measured in 55 control subjects, 57 patients with primary hyperparathyroidism (1°HPT), and 10 patients with chronic hypoparathyroidism.

In the group with 1° HPT, NcAMP was elevated in 52 patients (91%), and similar elevations were noted in subgroups of 26 patients with mild (serum calcium ≤10.7 mg/dl) or intermittent hypercalcemia, 19 patients with mild renal insufficiency (mean glomerular filtration rate, 64 ml/min), and 10 patients with moderate renal insufficiency (mean glomerular filtration rate, 43 ml/min). Plasma iPTH was increased in 41 patients (73%).

The development of a parametric expression for UcAMP was found to be critically important in the clinical interpretation of results for total cAMP excretion. Because of renal impairment in a large number of patients, the absolute excretion rate of cAMP correlated poorly with the hyperparathyroid state. Expressed as a function of creatinine excretion, UcAMP was elevated in 81% of patients with 1° HPT, but the nonparametric nature of the expression led to a number of interpretive difficulties. The expression of cAMP excretion as a function of glomerular filtration rate was developed on the basis of the unique features of cAMP clearance in man, and this expression, which provided elevated values in 51 (89%) of the patients with 1° HPT, avoided entirely the inadequacies of alternative expressions.

Results for NcAMP and UcAMP in nonazotemic and azotemic patients with hypoparathyroidism confirmed the validity of the measurements and the expressions employed.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 771
page 771
icon of scanned page 772
page 772
icon of scanned page 773
page 773
icon of scanned page 774
page 774
icon of scanned page 775
page 775
icon of scanned page 776
page 776
icon of scanned page 777
page 777
icon of scanned page 778
page 778
icon of scanned page 779
page 779
icon of scanned page 780
page 780
icon of scanned page 781
page 781
icon of scanned page 782
page 782
icon of scanned page 783
page 783
Version history
  • Version 1 (October 1, 1977): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts